Back
Chugai Pharmaceutical Vs. Nxera Pharma Industry Stock Comparison
Sell
30
CHGCY
Chugai Pharmaceutical
Last Price:
22.83
Seasonality Move:
5.98%
Sell
30
SOLTF
Nxera Pharma
Last Price:
7.64
Seasonality Move:
-1.93%
Sell
30
Chugai Pharmaceutical (CHGCY)
is a Sell
Is Chugai Pharmaceutical a Buy, Sell or Hold?
- The current Chugai Pharmaceutical [CHGCY] share price is $22.50. The Score for CHGCY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CHGCY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Nxera Pharma (SOLTF)
is a Sell
Is Nxera Pharma a Buy, Sell or Hold?
- The current Nxera Pharma [SOLTF] share price is $7.64. The Score for SOLTF is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- SOLTF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CHGCY Stock Price Chart
What is Chugai Pharmaceutical's stock price today?
-
The Chugai Pharmaceutical share price today is $22.50
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CHGCY is experiencing slight selling pressure.
SOLTF Stock Price Chart
What is Nxera Pharma's stock price today?
-
The Nxera Pharma share price today is $7.64
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SOLTF is experiencing slight buying pressure.
CHGCY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 38.26 | Sell |
Chaikin Money Flow: | -5282 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.28 - 24.44) | Sell |
Bollinger Bands (100): | (17.92 - 24.22) | Buy |
SOLTF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.37 | Sell |
Relative Strength Index (14 RSI): | 29.57 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.18 - 9.44) | Sell |
Bollinger Bands (100): | (8.69 - 10.21) | Sell |
CHGCY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.68 | Sell |
20-day SMA: | 23.81 | Sell |
50-day SMA: | 23.77 | Sell |
200-day SMA: | 19.58 | Buy |
8-day EMA: | 23.33 | Sell |
20-day EMA: | 23.62 | Sell |
50-day EMA: | 23.13 | Sell |
200-day EMA: | 20.01 | Buy |
SOLTF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.2 | Sell |
20-day SMA: | 8.72 | Sell |
50-day SMA: | 8.99 | Sell |
200-day SMA: | 9.7 | Sell |
8-day EMA: | 8.02 | Sell |
20-day EMA: | 8.49 | Sell |
50-day EMA: | 8.94 | Sell |
200-day EMA: | 9.8 | Sell |
Chugai Pharmaceutical Earnings Growth & CHGCY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nxera Pharma Earnings Growth & SOLTF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Chugai Pharmaceutical Technical Analysis
Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nxera Pharma Technical Analysis
Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |